drugset / Trial / NCT02105012
Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persistent Asthma
RandomizedCrossoverDouble-blindTreatment
Summary
Study to assess the efficacy and safety of four doses of budesonide inhalation aerosol (BD MDI, PT008) relative to placebo MDI in adult subjects with mild to moderate persistent asthma.
Timeline
- Start
- 2014-04-01
- Primary completion
- 2015-09-01
- Completion
- 2015-09-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 40 ug | Inhaled |
| Subject | Budesonide | Small molecule | 80 ug | Inhaled |
| Subject | Budesonide | Small molecule | 160 ug | Inhaled |
| Subject | Budesonide | Small molecule | 320 ug | Inhaled |